logo

Kempharm, Inc (KMPH)



Trade KMPH now with
  Date
  Headline
10/5/2018 9:29:06 AM KemPharm Prices Public Offering Of 8.33 Mln Common Shares At $3.00 Per Share
10/4/2018 4:08:27 PM KemPharm Announces Proposed Public Offering Of Common Stock
9/17/2018 7:33:48 AM KemPharm Announces Positive Topline Results From Intranasal Human Abuse Potential Trial Of KP415 Prodrug
9/11/2018 7:31:15 AM KemPharm Announces Positive Topline Results From Oral Human Abuse Potential Trial Of KP415 Prodrug
3/20/2018 7:33:43 AM KemPharm Announces Positive Topline Results From KP415 Pharmacokinetic Study In Children And Adolescents With ADHD
3/5/2018 9:22:13 AM New Drugs Approved In February
1/23/2018 7:35:33 AM KemPharm Receives Patent Grant For KP606, A Prodrug Of Oxycodone